<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02179398</url>
  </required_header>
  <id_info>
    <org_study_id>09-162 (MatPed 09-032)</org_study_id>
    <nct_id>NCT02179398</nct_id>
  </id_info>
  <brief_title>Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source</brief_title>
  <official_title>Impact of the Lab-score on Antibiotic Prescription Rate in Children Aged 7 Days to 3 Years Old With Fever Without Source.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioMérieux</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Detecting serious bacterial infections (SBI) in children presenting to the Pediatric
      Emergency Department (PED) with fever without source (FWS) is a frequent diagnostic
      challenge. The recently described Lab-score, based on the combined determination of
      Procalcitonin, C-Reactive Protein (CRP) and urine dipstick results, has been shown an
      accurate tool for SBI prediction on retrospective cohorts. The investigators aimed to assess
      the usefulness of the Lab-score in safely decreasing unnecessary antibiotic prescriptions in
      children with FWS, and to prospectively determine the diagnostic characteristics of the
      Lab-score compared to other classically used SBI biomarkers (white blood cell (WBC) count,
      band count and CRP).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antibiotic Prescription Rate</measure>
    <time_frame>at PED (Pediatric Emergency Department) presentation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of Serious Bacterial Infection</measure>
    <time_frame>at 72 hours from PED presentation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization Rate</measure>
    <time_frame>at PED presentation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of a Lab-score ≥ 3</measure>
    <time_frame>at 72 hours from PED presentation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of a Lab-score ≥ 3</measure>
    <time_frame>at 72 hours from PED presentation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of Standard Biological Marker for SBI</measure>
    <time_frame>at 72 hours from PED presentation</time_frame>
    <description>Sensitivity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of Standard Biological Marker for SBI</measure>
    <time_frame>at 72 hours from PED presentation</time_frame>
    <description>Specificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">278</enrollment>
  <condition>Fever Without Source</condition>
  <arm_group>
    <arm_group_label>Lab-score group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Allocation to the Lab-score group</intervention_name>
    <arm_group_label>Lab-score group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Allocation to the control group</intervention_name>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children aged 7 days to 3 years old

          -  fever without source ≥ 100.4°F (≥ 38.0°C)

        Exclusion Criteria:

          -  antibiotics received in the previous 48 hours

          -  underlying congenital or acquired immunodeficiency syndrome

          -  fever for more than 7 days at presentation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurence E Lacroix</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital, Geneva University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital, Geneva University Hospital</name>
      <address>
        <city>Geneva</city>
        <state>Geneva 14</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J. 2008 Jul;27(7):654-6. doi: 10.1097/INF.0b013e318168d2b4.</citation>
    <PMID>18536624</PMID>
  </reference>
  <reference>
    <citation>Galetto-Lacour A, Zamora SA, Andreola B, Bressan S, Lacroix L, Da Dalt L, Gervaix A. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source. Arch Dis Child. 2010 Dec;95(12):968-73. doi: 10.1136/adc.2009.176800. Epub 2010 Jun 1.</citation>
    <PMID>20515973</PMID>
  </reference>
  <reference>
    <citation>Bressan S, Gomez B, Mintegi S, Da Dalt L, Blazquez D, Olaciregui I, de la Torre M, Palacios M, Berlese P, Ruano A. Diagnostic performance of the lab-score in predicting severe and invasive bacterial infections in well-appearing young febrile infants. Pediatr Infect Dis J. 2012 Dec;31(12):1239-44. doi: 10.1097/INF.0b013e318266a9aa.</citation>
    <PMID>22760529</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2014</study_first_submitted>
  <study_first_submitted_qc>June 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2014</study_first_posted>
  <results_first_submitted>October 21, 2014</results_first_submitted>
  <results_first_submitted_qc>October 26, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2014</results_first_posted>
  <last_update_submitted>October 26, 2014</last_update_submitted>
  <last_update_submitted_qc>October 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Laurence Lacroix</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Fever without source</keyword>
  <keyword>Antibiotic prescription</keyword>
  <keyword>Serious bacterial infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lab-score Group</title>
          <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="134"/>
                <participants group_id="P2" count="144"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="131"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of obligatory data</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lab-score Group</title>
          <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="131"/>
            <count group_id="B2" value="140"/>
            <count group_id="B3" value="271"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.8" lower_limit="1.7" upper_limit="10.4"/>
                    <measurement group_id="B2" value="3.4" lower_limit="1.5" upper_limit="10.4"/>
                    <measurement group_id="B3" value="4.0" lower_limit="1.6" upper_limit="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fever duration</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Maximum temperature</title>
          <units>°C</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.3" spread="0.8"/>
                    <measurement group_id="B2" value="39.3" spread="0.8"/>
                    <measurement group_id="B3" value="39.3" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lab-score value</title>
          <description>Lab-score value ranges from 0 to 9. A cutoff point ≥3 was identified as the best Lab-score value for SBI prediction in the original derivation study. A child with a Lab-score &lt; 3 has a low SBI risk, whereas a child with a Lab-score value ≥3 has a high &gt;SBI risk.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.03" spread="2.62"/>
                    <measurement group_id="B2" value="2.04" spread="2.86"/>
                    <measurement group_id="B3" value="2.04" spread="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Presence of Serious Bacterial Infection (SBI)</title>
          <description>SBI was defined as isolation of a bacterial pathogen from the blood, the urine, the cerebrospinal fluid, the synovial fluid, the bone, the stools, or by presence of pneumonia (defined as presence of fever, ≥38°C or ≥100.4°F, cough, tachypnea, and a radiographic lung infiltrate).</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Antibiotic Prescription Rate</title>
        <time_frame>at PED (Pediatric Emergency Department) presentation</time_frame>
        <population>children 7 days – 36 months old presenting to the PED with fever without source (FWS) ≥38.0°C (≥ 100.4°F) after a thorough history and careful examination</population>
        <group_list>
          <group group_id="O1">
            <title>Lab-score Group</title>
            <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(white blood cell (WBC) and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: white blood cell (WBC) count, band count and C-Reactive Protein (CRP) determination.
(Procalcitonin (PCT) and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
          </group>
        </group_list>
        <measure>
          <title>Antibiotic Prescription Rate</title>
          <population>children 7 days – 36 months old presenting to the PED with fever without source (FWS) ≥38.0°C (≥ 100.4°F) after a thorough history and careful examination</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Serious Bacterial Infection</title>
        <time_frame>at 72 hours from PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lab-score Group</title>
            <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Serious Bacterial Infection</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalization Rate</title>
        <time_frame>at PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lab-score Group</title>
            <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalization Rate</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Power calculation suggested 97 patients should be enrolled in each group to give 80% power at the 5% level of significance to detect a 20% difference in antibiotic prescription rate</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.810</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensitivity of a Lab-score ≥ 3</title>
        <time_frame>at 72 hours from PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients 0-3 Years Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged 0 up to 36 months-old.</description>
          </group>
          <group group_id="O2">
            <title>Patients &lt; 3 Months Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged less than 3 months-old.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity of a Lab-score ≥ 3</title>
          <units>percentage of patients (sensitivity)</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="271"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.1" lower_limit="76.5" upper_limit="93.6"/>
                    <measurement group_id="O2" value="80.0" lower_limit="65.7" upper_limit="94.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Specificity of a Lab-score ≥ 3</title>
        <time_frame>at 72 hours from PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients 0-3 Years Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged 0 up to 36 months-old.</description>
          </group>
          <group group_id="O2">
            <title>Patients &lt; 3 Months Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged less than 3 months-old.</description>
          </group>
        </group_list>
        <measure>
          <title>Specificity of a Lab-score ≥ 3</title>
          <units>percentage of patients (specificity)</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="271"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.3" lower_limit="82.7" upper_limit="91.8"/>
                    <measurement group_id="O2" value="93.1" lower_limit="87.8" upper_limit="98.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensitivity of Standard Biological Marker for SBI</title>
        <description>Sensitivity of standard biological marker for SBI: WBC ≥ 15’000/mm³ and/or bands ≥ 1’500/mm³ and/or CRP ≥ 40 mg/L</description>
        <time_frame>at 72 hours from PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients 0-3 Years Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged 0 up to 36 months-old.</description>
          </group>
          <group group_id="O2">
            <title>Patients &lt; 3 Months Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged less than 3 months-old.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity of Standard Biological Marker for SBI</title>
          <description>Sensitivity of standard biological marker for SBI: WBC ≥ 15’000/mm³ and/or bands ≥ 1’500/mm³ and/or CRP ≥ 40 mg/L</description>
          <units>percentage of patients (sensitivity)</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="271"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.6" lower_limit="74.7" upper_limit="92.5"/>
                    <measurement group_id="O2" value="70.0" lower_limit="53.6" upper_limit="86.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Specificity of Standard Biological Marker for SBI</title>
        <description>Specificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1’500/mm³ and/or CRP ≥ 40 mg/L</description>
        <time_frame>at 72 hours from PED presentation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients 0-3 Years Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged 0 up to 36 months-old.</description>
          </group>
          <group group_id="O2">
            <title>Patients &lt; 3 Months Old</title>
            <description>Patients allocated to the Lab-score group OR to the control group, aged less than 3 months-old.</description>
          </group>
        </group_list>
        <measure>
          <title>Specificity of Standard Biological Marker for SBI</title>
          <description>Specificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1’500/mm³ and/or CRP ≥ 40 mg/L</description>
          <units>percentage of patients (specificity)</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="271"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.8" lower_limit="62.4" upper_limit="75.2"/>
                    <measurement group_id="O2" value="79.3" lower_limit="70.8" upper_limit="87.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lab-score Group</title>
          <description>Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection.
(WBC and band counts blinded to the physician in charge of the patient)
Allocation to the Lab-score group</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination.
(PCT and thus Lab-score blinded to the physician in charge of the patient).
Allocation to the control group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>heterogeneity in the total number of participating physicians (30)
recruitment in a tertiary care center (recruitment bias)</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Laurence Lacroix</name_or_title>
      <organization>Geneva University Hospital</organization>
      <phone>+41223725082</phone>
      <email>laurence.lacroix@hcuge.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

